Big Move For Adaptimmune Therapeutics plc
Fri, May 29, 2020 at 05:30 PM
Adaptimmune Therapeutics plc (ADAP:NASDAQ) soared at $11.07, a gain of 127.8%. The stock appeared on our News Catalysts scanner on Fri 29 May 20 at 12:23 PM in the 'BIOTECH' category. From Thu 14 May 20, the stock recorded 55.56% Up Days and 60.00% Green Days
The stock spiked on Fri 22 May 20 at $6.05 with a volume of 1M+, and its share price has been moving sideways in recent weeks.
About Adaptimmune Therapeutics plc (ADAP:NASDAQ)
Adaptimmune Therapeutics PLC along with its subsidiaries is a clinical-stage biopharmaceutical company. It is engaged in novel cancer immunotherapy products based on its T-cell receptor platform.
Top 10 Gainers:
- Adaptimmune Therapeutics plc (ADAP:NASDAQ), 127.78%
- Sonoma Pharmaceuticals, Inc. (SNOA:NASDAQ), 79.3%
- AgeX Therapeutics, Inc. (AGE:NYSEMKT), 49.67%
- Pacific Ethanol, Inc. (PEIX:NASDAQ), 36.82%
- Phio Pharmaceuticals Corp. (PHIO:NASDAQ), 36.16%
- Millendo Therapeutics, Inc. (MLND:NASDAQ), 34.34%
- Nabriva Therapeutics plc (NBRV:NASDAQ), 33.91%
- Allied Esports Entertainment Inc. (AESE:NASDAQ), 33.88%
- Digital Ally, Inc. (DGLY:NASDAQ), 33.35%
- Agenus Inc. (AGEN:NASDAQ), 29.51%